Ghana vs Western Pacific (WHO region): New cases tested for RR-/MDR-TB
Ghana
100.0%
in 2024
Western Pacific (WHO region)
89.0%
in 2024
Ghana rank
1st
Western Pacific (WHO region) rank
2nd
New cases tested for RR-/MDR-TB over time
- Ghana
- Western Pacific (WHO region)
How they compare
Ghana currently reports 100.0% against 89.0% in Western Pacific (WHO region), a difference of 11.0%.
That makes Ghana's figure about 1.1 times Western Pacific (WHO region)'s.
The two have swapped places 1 time across 17 shared years of data; in 2005 it was Western Pacific (WHO region) ahead.
Ghana ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
Across the 3 decades both report, Ghana averaged higher in 2 and Western Pacific (WHO region) in 1.
Head to head by decade
| Decade | Ghana | Western Pacific (WHO region) | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.2% | 1.3% | 1.1% | Western Pacific (WHO region) |
| 2010s | 40.6% | 26.1% | 14.5% | Ghana |
| 2020s | 99.2% | 83.2% | 16.0% | Ghana |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher new cases tested for rr-/mdr-tb, Ghana or Western Pacific (WHO region)?
- Ghana, at 100.0% against 89.0% in Western Pacific (WHO region) as of 2024.
- What is the difference in new cases tested for rr-/mdr-tb between Ghana and Western Pacific (WHO region)?
- 11.0%, with Ghana ahead.
- How many years of comparable data are there for Ghana and Western Pacific (WHO region)?
- 17 years are reported by both, from 2005 to 2024.
- How do Ghana and Western Pacific (WHO region) rank globally for new cases tested for rr-/mdr-tb?
- Ghana ranks 1st and Western Pacific (WHO region) ranks 2nd of 192 countries.
- Where does this data come from?
- World Health Organization, Global Health Observatory, published as New cases tested for RR-/MDR-TB (%). Statizoid refreshes it automatically from the source and publishes the full history for both places.